Anti-Liver Fibrosis Activity and the Potential Mode of Action of Ruangan Granules: Integrated Network Pharmacology and Metabolomics.

Shang, Xiaofei; Yuan, Huixin; Dai, Lixia; Liu, Yang; He, Jian; Chen, Huan; Li, Hongyan; Li, Xiuhui

Shang, Xiaofei; Yuan, Huixin; Dai, Lixia; Liu, Yang; He, Jian; Chen, Huan; Li, Hongyan; Li, Xiuhui.

Afiliación

Shang X; Beijing YouAn Hospital, Capital Medical University, Beijing, China.
Yuan H; Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, Lanzhou, China.
Dai L; Beijing YouAn Hospital, Capital Medical University, Beijing, China.
Liu Y; Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, Lanzhou, China.
He J; Beijing YouAn Hospital, Capital Medical University, Beijing, China.
Chen H; Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, Lanzhou, China.
Li H; Beijing YouAn Hospital, Capital Medical University, Beijing, China.
Li X; Beijing YouAn Hospital, Capital Medical University, Beijing, China.

Front Pharmacol ; 12: 754807, 2021.

Article en En | MEDLINE | ID: mdl-35115923

Palabras clave

liver fibrosis; metabolomics; mode of action; network pharmacology; ruangan granules

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google